Welcome
Support Centre
10 January 2009 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Evidence into Practice: evaluating a Child-centred intervention for diabetes medicine management
ISRCTN ISRCTN17551624
ClinicalTrials.gov identifier
Public title Evidence into Practice: evaluating a Child-centred intervention for diabetes medicine management
Scientific title
Acronym EPIC
Serial number at source 0001653
Study hypothesis Little evidence exists concerning the effectiveness of the types and formats of information that could empower children to make decisions regarding medicines and self-care. For children with type one diabetes, intensive structured education programmes exist, however there is insufficient evidence about the effectiveness of information underpinning these programmes or routine clinical management.

Aim:
To develop and evaluate an individually-tailored, age-appropriate information resource to support decision-making and self-care relating to insulin management and electronic blood glucose monitoring for children aged 6 - 18 years with type one diabetes, compared with available resources (if any) in routine clinical practice.

Objectives:
1. Review gold-standard clinical guidelines, currently available information including findings from completed Phase 1 of current SDO/145/2007 to identify best practice, and types/formats of information most likely to assist age-appropriate decision-making and choices concerning blood glucose monitoring and insulin management
2. Develop an age-appropriate child-centred information resource for children/young people, to support appropriate use of blood glucose meters to optimise management of and concordance with their insulin regime
3. Explore the utility of the resource within different contexts in which children manage their routine diabetes care (home, school, community) with and without support from parents or healthcare professionals, and in alternative settings
4. Explore how children with and without their parents, teachers, nurses, doctors use (or not) the information resource to support decision-making; in particular how children/parents 'self-prescribe' the correct (or incorrect) dose of insulin
5. Identify similarities and differences between the resource developed for adolescents and those available within adult diabetes services
6. Evaluate the resource within the context of routine diabetes care in relation to patient outcomes (diabetes-specific, health-related quality-of-life concordance, acceptability, ease of use, and glycaemic control)
7. Identify gaps in knowledge
Ethics approval Ethics approval pending as of 12/06/2008.
Study design Pragmatic randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Type one diabetes
Participants - inclusion criteria 1. Children aged 6 - 18 years, either sex
2. Type one diabetes
Participants - exclusion criteria 1. Severe learning difficulties
2. Significant social problems
3. Needle phobias
Anticipated start date 01/02/2009
Anticipated end date 01/09/2010
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 200
Interventions The investigation is a mixed-method study informed by the 'Promoting Action on Research Implementation in Health Services' (PARIHS) framework which has been widely used to inform design and evaluation of evidence-into-practice initiatives.

To meet our objectives which are aligned with the phases of the Medical Research Council (MRC) framework for randomised controlled trials (RCTs) of complex interventions we have designed a four-stage study:
Stage 1: Review and, where appropriate, undertake further work to identify types/formats of information most likely to assist age-appropriate decision-making/choices related to children/young people with type one diabetes. Duration: April 2008 to October 2008.
Stage 2: Construct an exemplar information resource, piloting for variations as necessary. Duration: November 2008 to October 2009.
Stage 3: Conduct a pragamatic evaluation to assess utility, acceptability effectiveness and cost effectiveness of the information resource. Duration: November 2009 to June 2010.
Stage 4: Undertake data synthesis and comparative analysis. Duration: July 2009 to March 2011.

The intervention lasts for 8 months with a follow-up at 3 months from baseline and 3 months from first follow-up.
Primary outcome measure(s) Choice of outcomes is guided by Health Technology Assessment (HTA) commissioned systematic reviews recommending that HbA1c (glycaemic control measure) is not the appropriate primary outcome on which to assess benefits of an intervention designed to more directly effect behaviour/self-management. Therefore, the primary outcome measure is diabetes self-efficacy and quality-of-life using the Diabetes Pediatric Quality of Life Inventory (PedsQol).

Outcomes will be measured at baseline, 3 months (follow-up 1) and 6 months (follow-up 2).
Secondary outcome measure(s) 1. HbA1c
2. Generic quality of life
3. Routinely collected NHS/child-held data costs
4. Service use
5. Acceptability/utility

Outcomes will be measured at baseline, 3 months (follow-up 1) and 6 months (follow-up 2).
Sources of funding National Institute for Health Research (NIHR) (UK) - Service Delivery and Organisation (SDO) Programme (ref: 0001653)
Trial website
Publications
Contact name Prof  Anne  Williams
  Address Nursing, Health and Social Care Research Centre
School of Nursing & Midwifery Studies
Eastgate House
35-43 Newport Road
  City/town Cardiff
  Zip/Postcode CF24 0AB
  Country United Kingdom
  Tel +44 (0)29 2091 7816
  Fax +44 (0)29 2091 7803
  Email awglanrhyd@aol.com
Sponsor Cardiff University (UK)
  Address 7th Floor
30-36 Newport Road
  City/town Cardiff
  Zip/Postcode CF24 0DE
  Country United Kingdom
  Tel +44 (0)29 2087 5834
  Fax +44 (0)29 2087 4189
  Email davieskp2@cf.ac.uk
  Sponsor website: http://www.cardiff.ac.uk/
Date applied 12/06/2008
Last edited 11/07/2008
Date ISRCTN assigned 23/06/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central